Topological effects of EBNA 1 on oriP.
Orlowski
R
R
Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut 06510.
Miller
G
G
D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000956:Antigens, Viral / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D001483:Base Sequence; D001665:Binding Sites; D004278:DNA, Superhelical / Q000378:metabolism; D004279:DNA, Viral / Q000378:metabolism*; D043223:Deoxyribonuclease IV (Phage T4-Induced); D004706:Endodeoxyribonucleases / Q000378:metabolism; D019309:Epstein-Barr Virus Nuclear Antigens; D004926:Escherichia coli / Q000235:genetics; D029968:Escherichia coli Proteins; D005814:Genes, Viral; D004854:Herpesvirus 4, Human / Q000235:genetics*; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation / Q000187:drug effects; D010957:Plasmids; D011994:Recombinant Proteins / Q000378:metabolism / Q000494:pharmacology; D012091:Repetitive Sequences, Nucleic Acid; D014169:Transformation, Bacterial
D000911:Antibodies, Monoclonal; D000956:Antigens, Viral; D004278:DNA, Superhelical; D004279:DNA, Viral; D019309:Epstein-Barr Virus Nuclear Antigens; D029968:Escherichia coli Proteins; D011994:Recombinant Proteins; D004706:Endodeoxyribonucleases; D043223:Deoxyribonuclease IV (Phage T4-Induced); C468972:endonuclease IV, E coli